The challenges of antirheumatic therapy and travel-associated infections

Rheumatology (Oxford). 2022 Mar 2;61(3):886-888. doi: 10.1093/rheumatology/keab686.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Humans
  • Travel*
  • Travel-Related Illness

Substances

  • Antirheumatic Agents